MicroRNA-Responsive DNA-Programmed Nanomedicine with Controllability of Cascaded Events for Cancer Therapy Enhancement

Yi Qin,Weipan Peng,Xiaoqun Gong,Dianming Zhou,Wenna Li,Minghui Chen,Guowei Lian,Jin Chang,Tao Wang
DOI: https://doi.org/10.1021/acsmacrolett.1c00136
IF: 5.8
2021-05-10
ACS Macro Letters
Abstract:Chemotherapy is a prime tool for cancer clinical therapy. The effectiveness has been improved considerably with the assistance of nanotechnology. However, it still meets the challenge of unsatisfied therapeutic effects caused by multidrug resistance and uncontrollable drug release. For further enhancement of the treatment performance, we develop a kind of microRNA-responsive nanomedicine that uses the biomarker microRNA-21 as a trigger of cascaded killing effects on cancer cells, including chemotherapy and gene silencing. The nanomedicine consists of a gold nanoparticle core and a DNA layer. Strand migrations within the layer can accurately control the events of anticancer drug doxorubicin release and multidrug-resistant-associated protein 1 downregulation, yielding an alleviation of multidrug resistance and enhanced killing on cancer cells. This work demonstrates a microRNA-responsive nanomedicine in combination with chemotherapy and gene silencing, which paves the way to the advancement of DNA-based nanomedicine for cancer theranostics.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsmacrolett.1c00136?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsmacrolett.1c00136</a>.Experimental details; fluorescence dye release data; absorbance spectra; Dox loading data; fluorescence emission spectra; and time optimization (<a class="ext-link" href="/doi/suppl/10.1021/acsmacrolett.1c00136/suppl_file/mz1c00136_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
polymer science
What problem does this paper attempt to address?